Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Cell Death & Disease|August 11, 2017
BET bromodomain inhibitors synergize with ATR inhibitors in melanomaSomsundar Veppil Muralidharan, Berglind Osk Einarsdottir, Joydeep Bhadury, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2014
BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphomaJoydeep Bhadury, Lisa M Nilsson, Somsundar Veppil Muralidharan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2009
Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in miceJenny Nilsson-Ohman, Gunilla Nordin Fredrikson, Lisa M Nilsson-Berglund, et al.
Cancer Research|January 10, 2019
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout MiceElin M V Forsberg, Mattias F Lindberg, Henrik Jespersen, et al.
Cancer Cell|May 17, 2005
Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formationJonas A Nilsson, Ulrich B Keller, Troy A Baudino, et al.
Cancers|February 11, 2023
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion DogsElin M V Forsberg, Rebecca Riise, Sara Saellström, et al.
BMC Cancer|May 4, 2019
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label studyHenrik Jespersen, Roger Olofsson Bagge, Gustav Ullenhag, et al.
Oncotarget|September 18, 2014
Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisionsBerglind O Einarsdottir, Roger Olofsson Bagge, Joydeep Bhadury, et al.
Journal for Immunotherapy of Cancer|March 18, 2026
Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial)Axel Nelson, Rebecca Riise, Samuel Alsén, et al.
Cancer Research Communications|June 28, 2023
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint ImmunotherapyVasu R Sah, Henrik Jespersen, Joakim Karlsson, et al.
Pageof 4